Stock GH GUARDANT HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Guardant Health, Inc.

Equities

GH

US40131M1099

Market Closed - Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
28.41 USD -1.59% Intraday chart for Guardant Health, Inc. -3.33% +5.03%
Jun. 28 Top Premarket Gainers MT
Jun. 28 Guggenheim Upgrades Guardant Health to Buy From Neutral, Price Target at $36 MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Top Premarket Gainers
MT
Guggenheim Upgrades Guardant Health to Buy From Neutral, Price Target at $36
MT
Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors and Chairperson of Audit Committee
CI
Transcript : Guardant Health, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 02:00 PM
Canaccord Genuity Adjusts Price Target on Guardant Health to $38 From $30, Maintains Buy Rating
MT
Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
BU
Guardant Health Introduces New Guardant360 Tissuenext Test with Nearly 500 Biomarkers to Identify More Treatment Options for Patients with Advanced Cancer
CI
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
BU
Jefferies Initiates Guardant Health at Buy Rating With $32 Price Target
MT
Guardant Health Named to TIME100 Most Influential Companies
BU
Guardant Health : 2024 ESG Report
PU
Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening
BU
Sector Update: Health Care Stocks Softer in Friday Afternoon Trading
MT
Guardant Health's Shares Rise as Colorectal Cancer Detection Test Gets FDA Panel Recommendation
MT
Sector Update: Health Care Stocks Advance Pre-Bell Friday
MT
Sector Update: Health Care
MT
Wall Street Rebounds From Thursday's Slide, Driving Narrow Gains for US Equity Futures Pre-Bell
MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Hope for September Interest Rate Cuts
MT
Top Premarket Gainers
MT
Guardant Health Says Colorectal Cancer Detection Test Receives FDA Panel Recommendation
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GH Stock
  4. News Guardant Health, Inc.